Evidence map›Paper›PMID 22038157›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2012

Trace amine associated receptor 1 signaling in activated lymphocytes.

Michael W Panas, Zhihua Xie, Helen N Panas, Marius C Hoener, Eric J Vallender, Gregory M Miller

Registry-linked trialAbstract read
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03825536 (Short-term Effects of Methamphetamine Exposure on Residual Viral Transcription During Treated HIV Disease), which is not on this map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03825536 phase4completednot on this mapstarted 2021, after this paper: background citation

Short-term Effects of Methamphetamine Exposure on Residual Viral Transcription During Treated HIV Disease

TypeinterventionalSponsorUniversity of California, San FranciscoRan2021 to 2023Enrolled14ConditionsHIV-1-infection, Methamphetamine-dependenceArmsOral Methamphetamine, Placebo oral capsule
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 76 citations in OpenAlex.

  1. Preclinical development of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. TAAR1 Regulates Purinergic-induced TNF Secretion from Peripheral, But Not CNS-resident, Macrophages.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Article
  8. Trace amine-associated receptor 1 and drug abuse.Advances in pharmacology (San Diego, Calif.) · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. CTGF induces tenogenic differentiation and proliferation of adipose-derived stromal cells.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2019
    Article
  20. Methamphetamine decreases KJournal of neurochemistry · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Michael W PanasBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Zhihua Xie
Helen N Panas
Marius C Hoener
Eric J Vallender
Gregory M Miller
Harvard University · USNew England Biolabs (United States) · USRoche (Switzerland) · CH

Funding

ZETA CHAIN OF T CELL RECEPTOR INTERACTS W/ NEF OF SIV &HIV2P51RR000168 · NCRR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROWLETT, JAMES K · 1985 to 2011
$139.3M
Epigenetic Regulation of Serotonin:Relevance to HIV and Methamphetamine AbuseR21DA030177 · NIDA · HARVARD MEDICAL SCHOOL · PI MILLER, GREGORY MICHAEL · 2010 to 2012
$928k
Drug Abuse-related Neurobiology and Genetic Variance Modeled in Rhesus MonkeysK02DA025697 · NIDA · HARVARD MEDICAL SCHOOL · PI MILLER, GREGORY MICHAEL · 2009 to 2013
$615k
MOUSE MODELS OF CANCER, BONE DISEASE, AND LACTATIONK26RR000168 · NCRR · OHIO STATE UNIVERSITY · PI ROSOL, THOMAS J · 2000 to 2004
$547k
NCRR NIH HHS K26 RR000168NCRR NIH HHS P51 RR000168NCRR NIH HHS RR00168NIDA NIH HHS DA025697NIDA NIH HHS DA030177NIDA NIH HHS K02 DA025697NIDA NIH HHS R21 DA030177
6 · The paper itself

Abstract

Although most research to date on Trace Amine Associated Receptor 1 (TAAR1) has focused on its role in the brain, it has been recognized since its discovery in 2001 that TAAR1 mRNA is expressed in peripheral tissues as well, suggesting that this receptor may play a role in non-neurological pathways. This study reports TAAR1 expression, signaling and functionality in rhesus monkey lymphocytes. We detected a high level of TAAR1 protein in immortalized rhesus monkey B cell lines and a significant upregulation of TAAR1 protein expression in rhesus monkey lymphocytes following PHA treatment. Through screening a wide range of signaling pathways for their upregulation following TAAR1 activation by its potent agonist methamphetamine, we identified two transcription factors, CREB and NFAT, which are commonly associated with immune activation. Furthermore, we observed a TAAR1-dependent phosphorylation of PKA and PKC following treatment with methamphetamine in transfected HEK293 cells, immortalized rhesus monkey B cells and PHA-activated rhesus monkey lymphocytes. Accordingly, the high levels of TAAR1 that we observed on lymphocytes are inducible and fully functional, capable of transmitting a signal likely via PKA and PKC activation following ligand binding. More importantly, an increase in TAAR1 receptor expression is concomitant with lymphocyte immune activation, suggesting a possible role for TAAR1 in the generation or regulation of an immune response. TAAR1 is emerging as a potential therapeutic target, with regard to its ability to modulate brain monoamines. The current data raises the possibility that TAAR1-targeted drugs may also alter immune function.

Indexed as

AnimalsBenzamidesBlotting, WesternCentral Nervous System StimulantsCyclic AMP-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinHEK293 CellsHumansLuciferasesLymphocyte ActivationLymphocytesMacaca mulattaMethamphetamineNFATC Transcription FactorsProtein Kinase CPyrrolidinesBenzamidesCentral Nervous System StimulantsCyclic AMP-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinLuciferasesMethamphetamineN-(3-ethoxyphenyl)-4-pyrrolidin-1-yl-3-trifluoromethylbenzamideNFATC Transcription FactorsProtein Kinase CPyrrolidinesReceptors, G-Protein-CoupledTrace Amine-Associated Receptors

Identifiers

PMID22038157
PMCPMC3593117
OpenAlexW2077527828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.